Home > JEP>

Prof. Roberto Manfredi

University of Bologna, Italy


Email: roberto.manfredi@unibo.it



2005 Associate Professor of Infectious Diseases, University of Bologna

1993  Senior Consultant in Infectious Diseases, S. Orsola Hospital

1992 Diploma of Specialist in Infectious Diseases, University of Bologna

1988 MD, University of Bologna


Publications (Selected)

  1. L. Calza, F. Trapani, C. Salvadori, V. Colangeli, R. Manfredi, P. Viale. Rosuvastatin, pravastatin, and atorvastatin for the treatment of hypercholesteroleamia in HIV-infected patients receiving protease inhibitors. A 36-month follow-up.Proceedings of the 13th European AIDS Conference (EACS). Belgrade (Serbia), 12-15/10/2011; Poster PE 9.2/6
  2. R. Manfredi.Procedure di screening, misure comportamentali e strumenti terapeutici per il controllo dell’infezione da HIV: un modello statunitense.Care 2011; 13 (5):9-11
  3. S. Sabbatani, S. Fiorino, E. Chili, R. Manfredi. Should knowlesi malaria in Southeast Asia impose a global health alert? Journal of Bacteriology and Parasitology 2011; 8 (Suppl. 2):2-4
  4. R. Manfredi,L. Calza, V. Colangeli, N. Dentale, G. Verucchi. Acute renal injury during HIV infection treated with combination antiretroviral therapy, and multiple underlying comorbidities and drug treatments. Implications of an underlying tenofovir therapy. An intriguing case report, and literature review. Diabetes Internacional 2011; 3:59-78
  5. L. Calza, R. Manfredi, F. Trapani, C. Salvadori, V. Colangeli, M. Borderi, G. Grossi, R. Motta, P. Viale. Lopinavir/ritonavir trough concentrations with the tablet formulation in HIV-1-infected women during the third trimester of pregnancy. Scandinavian Journal of Infectious Diseases 2012; 44:381-387
  6. R. Manfredi,A. Nanetti, P. Dal Monte, G. Battista, L. Calza. Unexpectedly slow clinical, bacteriological, and radiological response of pulmonary tuberculosis to standard pharmacological therapy. Which role for novel antimicrobial compounds with anti-mycobacterial activity? In: “Advances in Medicine and Biology”, Leon V. Berhardt Editor, Nova Science Publishers, New York, USA; 2012; 30:233-246
  7. S. Sabbatani, S. Fiorino, R. Manfredi. Plasmodium knowlesi:from Malaysia, a novel health care threat. Le Infezioni in Medicina 2012; 20:5-11
  8. R. Manfredi, L. Calza, V. Colangeli, N. Dentale, G. Verucchi. Kidney failure during HIV disease treated with tenofovir, multiple concurremt diseases and drug therapies. Reviews in Health Care 2012; 3:83-112
  9. R. Manfredi, B. Piergentili, G. Marinacci, L. Calza. Atypical progressive multifocal leukoecnephalopathy in HIV with a high CD4 count: the use of magnetic resonance imaging plus spectrometry studies. International Jourmal of STD and AIDS 2012; 23:e35-e38
  10. S. Sabbatani, R. Manfredi, C. Fulgaro.Long-term stabilized immunological-virological parameters of HIV infection in an AIDS presenter followed for 20 years, with irregular or no antiretroviral therapy. International Jourmal of STD and AIDS 2012; 23:e46-e47
  11. R. Manfredi, N. Dentale, L. Calza.Spontaneous clearance of chronic hepatitis C infection in a patient with a 20-year-old HV-hepatitis C co-infection and chronic active hepatitis.International Jourmal of STD and AIDS 2012; 23:e48-e50
  12. L. Calza, F. Trapani, M. Bartoletti, R. ManfrediV. Colangeli, M. Borderi, G. Grossi, R. Motta, P. Viale. Statin therapy decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-alpha in HIV.infected patients treated with ritonavir-boosted protease inhibitors. HIV Clinical Trials 2012; 13:153-161
  13. L. Calza, E. Magistrelli, C. Salvadori, F. Trapani, V. Colangeli, R. Manfredi, G. Verucchi, C. Serra, P. Viale.Significant decrease in serum inflammation markers and carotid intima-media thickness in HIV-infected patients on HAART and treated with rosuvastatin or atorvastatin for 24 months. Proceedings of the 4th Italian Conference on AIDS and Retroviruses (ICAR), Napoli, 10-12/6/2012, OC 47
  14. L. Calza, E. Magistrelli, V. Colangeli, R. Manfredi, M.A. Di Bari, M. Borderi, P. Viale.Incidence of renal toxicity after a 24-month follow-up in naïve patients starting tenofovir/emtricitabine associated with efavirenz, atazanavir/ritonavir or lopinavir/ritonavir. Proceedings of the 4th Italian Conference on AIDS and Retroviruses (ICAR), Napoli, 10-12/6/2012, P 50
  15. L.E. Weimer, V. Fragola, M. Floridia, G. Guaraldi, N. Ladisa, D. Francisci, N. Bellagamba, A. Degli Antoni, G. Parruti, A. Giacometti, P.E. Manconi, A. Vivarelli, G. D’Ettorre, M.S. Mura, S. Cicalini, G. Ceccarelli, R. Preziosi, L. Sighinolfi, G. Verucchi, R. Manfredi,V. Tozzi, M. Tavio, M. Andreoni, R. Bucciardini, for the ISS-NIA Stydy Group.Response profile of raltegravir-based regimens in HIV-infected patients coinfected with hepatitis C or B virus. Proceedings of the 4thItalian Conference on AIDS and Retroviruses (ICAR), Napoli, 10-12/6/2012, P 62
  16. L. Calza, E. Magistrelli, F. Trapani, V. Colangeli, R. Manfredi,M.A. Di Bari, G. Grossi, R. Motta, P. Viale. Plasma levels of inflammatory markers in HIV-positive naïve patients starting tenofovir/emtricitabine or abacavir/lamivudine plus efavirenz compared to naïve subjects not receiving HAART: preliminary results. Proceedings of the 4th Italian Conference on AIDS and Retroviruses (ICAR), Napoli, 10-12/6/2012, P 76
  17. S. Sabbatani, R. Manfredi, P. Ortolani, F.F. Trapani, P. Viale. Myopericarditis during a primary Epstein-Barr virus infection in an otherwise healthy young adult. An unusual and insidious complication. Case report and 60-year literature review.Le Infezioni in Medicina 2012; 20:75-81
  18. S. Sabbatani, R. Manfredi,S. Fiorino.La peste di Giustiniano (prima parte).Le Infezioni in Medicina 2012; 20:125-139